82R1355 AJZ-D
 
  By: Zaffirini S.B. No. 55
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the administration of psychoactive medications to
  persons receiving services in certain facilities.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 592.038, Health and Safety Code, is
  amended by adding Subsection (d) to read as follows:
         (d)  Each client has the right to refuse psychoactive
  medication, as provided by Subchapter E.
         SECTION 2.  Section 592.054(b), Health and Safety Code, is
  amended to read as follows:
         (b)  Notwithstanding Subsection (a), consent is required
  for:
               (1)  all surgical procedures; and
               (2)  as provided by Section 592.083, the administration
  of psychoactive medications.
         SECTION 3.  Chapter 592, Health and Safety Code, is amended
  by adding Subchapter E to read as follows:
  SUBCHAPTER E. ADMINISTRATION OF PSYCHOACTIVE MEDICATIONS
         Sec. 592.081.  DEFINITIONS. In this subchapter:
               (1)  "Capacity" means a client's ability to:
                     (A)  understand the nature and consequences of a
  proposed treatment, including the benefits, risks, and
  alternatives to the proposed treatment; and
                     (B)  make a decision whether to undergo the
  proposed treatment.
               (2)  "Medication-related emergency" means a situation
  in which it is immediately necessary to administer medication to a
  client to prevent:
                     (A)  imminent probable death or substantial
  bodily harm to the client because the client:
                           (i)  overtly or continually is threatening
  or attempting to commit suicide or serious bodily harm; or
                           (ii)  is behaving in a manner that indicates
  that the client is unable to satisfy the client's need for
  nourishment, essential medical care, or self-protection; or
                     (B)  imminent physical or emotional harm to
  another because of threats, attempts, or other acts the client
  overtly or continually makes or commits.
               (3)  "Psychoactive medication" means a medication
  prescribed for the treatment of symptoms of psychosis or other
  severe mental or emotional disorders and that is used to exercise an
  effect on the central nervous system to influence and modify
  behavior, cognition, or affective state when treating the symptoms
  of mental illness. "Psychoactive medication" includes the
  following categories when used as described in this subdivision:
                     (A)  antipsychotics or neuroleptics;
                     (B)  antidepressants;
                     (C)  agents for control of mania or depression;
                     (D)  antianxiety agents;
                     (E)  sedatives, hypnotics, or other
  sleep-promoting drugs; and
                     (F)  psychomotor stimulants.
         Sec. 592.082.  ADMINISTRATION OF PSYCHOACTIVE MEDICATION.
  (a) A person may not administer a psychoactive medication to a
  client receiving voluntary or involuntary residential care
  services who refuses the administration unless:
               (1)  the client is having a medication-related
  emergency;
               (2)  the refusing client's representative authorized by
  law to consent on behalf of the client has consented to the
  administration;
               (3)  the administration of the medication regardless of
  the client's refusal is authorized by an order issued under Section
  592.086; or
               (4)  the administration of the medication regardless of
  the client's refusal is authorized by an order issued under Article
  46B.086, Code of Criminal Procedure.
         (b)  Consent to the administration of psychoactive
  medication given by a client or by a person authorized by law to
  consent on behalf of the client is valid only if:
               (1)  the consent is given voluntarily and without
  coercive or undue influence;
               (2)  the treating physician or a person designated by
  the physician provides the following information, in a standard
  format approved by the department, to the client and, if
  applicable, to the client's representative authorized by law to
  consent on behalf of the client:
                     (A)  the specific condition to be treated;
                     (B)  the beneficial effects on that condition
  expected from the medication;
                     (C)  the probable health care consequences of not
  consenting to the medication;
                     (D)  the probable clinically significant side
  effects and risks associated with the medication;
                     (E)  the generally accepted alternatives to the
  medication, if any, and why the physician recommends that they be
  rejected; and
                     (F)  the proposed course of the medication;
               (3)  the client and, if appropriate, the client's
  representative authorized by law to consent on behalf of the client
  are informed in writing that consent may be revoked; and
               (4)  the consent is evidenced in the client's clinical
  record by a signed form prescribed by the residential care facility
  or by a statement of the treating physician or a person designated
  by the physician that documents that consent was given by the
  appropriate person and the circumstances under which the consent
  was obtained.
         (c)  If the treating physician designates another person to
  provide the information under Subsection (b), then, not later than
  two working days after that person provides the information,
  excluding weekends and legal holidays, the physician shall meet
  with the client and, if appropriate, the client's representative
  who provided the consent, to review the information and answer any
  questions.
         (d)  A client's refusal or attempt to refuse to receive
  psychoactive medication, whether given verbally or by other
  indications or means, shall be documented in the client's clinical
  record.
         (e)  In prescribing psychoactive medication, a treating
  physician shall:
               (1)  prescribe, consistent with clinically appropriate
  medical care, the medication that has the fewest side effects or the
  least potential for adverse side effects, unless the class of
  medication has been demonstrated or justified not to be effective
  clinically; and
               (2)  administer the smallest therapeutically
  acceptable dosages of medication for the client's condition.
         (f)  If a physician issues an order to administer
  psychoactive medication to a client without the client's consent
  because the client is having a medication-related emergency:
               (1)  the physician shall document in the client's
  clinical record in specific medical or behavioral terms the
  necessity of the order and that the physician has evaluated but
  rejected other generally accepted, less intrusive forms of
  treatment, if any; and
               (2)  treatment of the client with the psychoactive
  medication shall be provided in the manner, consistent with
  clinically appropriate medical care, least restrictive of the
  client's personal liberty.
         Sec. 592.083. ADMINISTRATION OF MEDICATION TO CLIENT
  COMMITTED TO RESIDENTIAL CARE FACILITY. (a) In this section,
  "ward" has the meaning assigned by Section 601, Texas Probate Code.
         (b)  A person may not administer a psychoactive medication to
  a client who refuses to take the medication voluntarily unless:
               (1)  the client is having a medication-related
  emergency;
               (2)  the client is under an order issued under Section
  592.086 authorizing the administration of the medication
  regardless of the client's refusal; or
               (3)  the client is a ward who is 18 years of age or older
  and the guardian of the person of the ward consents to the
  administration of psychoactive medication regardless of the ward's
  expressed preferences regarding treatment with psychoactive
  medication.
         Sec. 592.084.  PHYSICIAN'S APPLICATION FOR ORDER TO
  AUTHORIZE PSYCHOACTIVE MEDICATION; DATE OF HEARING. (a) A
  physician who is treating a client may file an application in a
  probate court or a court with probate jurisdiction on behalf of the
  state for an order to authorize the administration of a
  psychoactive medication regardless of the client's refusal if:
               (1)  the physician believes that the client lacks the
  capacity to make a decision regarding the administration of the
  psychoactive medication;
               (2)  the physician determines that the medication is
  the proper course of treatment for the client; and
               (3)  the client has been committed to a residential
  care facility under Subchapter C, Chapter 593, or other law or an
  application for commitment to a residential care facility under
  Subchapter C, Chapter 593, has been filed for the client.
         (b)  An application filed under this section must state:
               (1)  that the physician believes that the client lacks
  the capacity to make a decision regarding administration of the
  psychoactive medication and the reasons for that belief;
               (2)  each medication the physician wants the court to
  compel the client to take;
               (3)  whether an application for commitment to a
  residential care facility under Subchapter C, Chapter 593, has been
  filed;
               (4)  whether an order committing the client to a
  residential care facility has been issued and, if so, under what
  authority it was issued;
               (5)  the physician's diagnosis of the client; and
               (6)  the proposed method for administering the
  medication and, if the method is not customary, an explanation
  justifying the departure from the customary methods.
         (c)  An application filed under this section must be filed
  separately from an application for commitment to a residential care
  facility.
         (d)  The hearing on the application may be held on the same
  date as a hearing on an application for commitment to a residential
  care facility under Subchapter C, Chapter 593, but the hearing must
  be held not later than 30 days after the filing of the application
  for the order to authorize psychoactive medication. If the hearing
  is not held on the same date as the application for commitment to a
  residential care facility under Subchapter C, Chapter 593, and the
  client is transferred to a residential care facility in another
  county, the court may transfer the application for an order to
  authorize psychoactive medication to the county where the client
  has been transferred.
         (e)  Subject to the requirement in Subsection (d) that the
  hearing shall be held not later than 30 days after the filing of the
  application, the court may grant one continuance on a party's
  motion and for good cause shown. The court may grant more than one
  continuance only with the agreement of the parties.
         Sec. 592.085.  RIGHTS OF CLIENT. A client for whom an
  application for an order to authorize the administration of a
  psychoactive medication is filed is entitled:
               (1)  to be represented by a court-appointed attorney
  who is knowledgeable about issues to be adjudicated at the hearing;
               (2)  to meet with that attorney as soon as is
  practicable to prepare for the hearing and to discuss any of the
  client's questions or concerns;
               (3)  to receive, immediately after the time of the
  hearing is set, a copy of the application and written notice of the
  time, place, and date of the hearing;
               (4)  to be informed, at the time personal notice of the
  hearing is given, of the client's right to a hearing and right to
  the assistance of an attorney to prepare for the hearing and to
  answer any questions or concerns;
               (5)  to be present at the hearing;
               (6)  to request from the court an independent expert;
  and
               (7)  to be notified orally, at the conclusion of the
  hearing, of the court's determinations of the client's capacity and
  best interest.
         Sec. 592.086.  HEARING AND ORDER AUTHORIZING PSYCHOACTIVE
  MEDICATION. (a) The court may issue an order authorizing the
  administration of one or more classes of psychoactive medication to
  a client who:
               (1)  has been committed to a residential care facility;
  or
               (2)  is in custody awaiting trial in a criminal
  proceeding and was committed to a residential care facility in the
  six months preceding a hearing under this section.
         (b)  The court may issue an order under this section only if
  the court finds by clear and convincing evidence after the hearing:
               (1)  that the client lacks the capacity to make a
  decision regarding the administration of the proposed medication
  and that treatment with the proposed medication is in the best
  interest of the client; or
               (2)  if the client was committed to a residential care
  facility by a criminal court with jurisdiction over the client,
  that treatment with the proposed medication is in the best interest
  of the client, and either:
                     (A)  the client presents a danger to the client or
  others in the residential care facility in which the client is being
  treated as a result of a mental disorder or mental defect as
  determined under Section 592.087; or
                     (B)  the client:
                           (i)  has remained confined in a correctional
  facility, as defined by Section 1.07, Penal Code, for a period
  exceeding 72 hours while awaiting transfer for competency
  restoration treatment; and
                           (ii)  presents a danger to the client or
  others in the correctional facility as a result of a mental disorder
  or mental defect as determined under Section 592.087.
         (c)  In making the finding that treatment with the proposed
  medication is in the best interest of the client, the court shall
  consider:
               (1)  the client's expressed preferences regarding
  treatment with psychoactive medication;
               (2)  the client's religious beliefs;
               (3)  the risks and benefits, from the perspective of
  the client, of taking psychoactive medication;
               (4)  the consequences to the client if the psychoactive
  medication is not administered;
               (5)  the prognosis for the client if the client is
  treated with psychoactive medication;
               (6)  alternative, less intrusive treatments that are
  likely to produce the same results as treatment with psychoactive
  medication; and
               (7)  less intrusive treatments likely to secure the
  client's consent to take the psychoactive medication.
         (d)  A hearing under this subchapter shall be conducted on
  the record by the probate judge or judge with probate jurisdiction,
  except as provided by Subsection (e).
         (e)  A judge may refer a hearing to a magistrate or
  court-appointed associate judge who has training regarding
  psychoactive medications. The magistrate or associate judge may
  effectuate the notice, set hearing dates, and appoint attorneys as
  required by this subchapter. A record is not required if the
  hearing is held by a magistrate or court-appointed associate judge.
         (f)  A party is entitled to a hearing de novo by the judge if
  an appeal of the magistrate's or associate judge's report is filed
  with the court before the fourth day after the date the report is
  issued. The hearing de novo shall be held not later than the 30th
  day after the date the application for an order to authorize
  psychoactive medication was filed.
         (g)  If a hearing or an appeal of an associate judge's or
  magistrate's report is to be held in a county court in which the
  judge is not a licensed attorney, the proposed client or the
  proposed client's attorney may request that the proceeding be
  transferred to a court with a judge who is licensed to practice law
  in this state. The county judge shall transfer the case after
  receiving the request, and the receiving court shall hear the case
  as if it had been originally filed in that court.
         (h)  As soon as practicable after the conclusion of the
  hearing, the client is entitled to have provided to the client and
  the client's attorney written notification of the court's
  determinations under this section. The notification shall include
  a statement of the evidence on which the court relied and the
  reasons for the court's determinations.
         (i)  An order entered under this section shall authorize the
  administration to a client, regardless of the client's refusal, of
  one or more classes of psychoactive medications specified in the
  application and consistent with the client's diagnosis. The order
  shall permit an increase or decrease in a medication's dosage,
  restitution of medication authorized but discontinued during the
  period the order is valid, or the substitution of a medication
  within the same class.
         (j)  The classes of psychoactive medications in the order
  must conform to classes determined by the department.
         (k)  An order issued under this section may be reauthorized
  or modified on the petition of a party. The order remains in effect
  pending action on a petition for reauthorization or modification.
  For the purpose of this subsection, "modification" means a change
  of a class of medication authorized in the order.
         (l)  For a client described by Subsection (b)(2)(B), an order
  issued under this section:
               (1)  authorizes the initiation of any appropriate
  mental health treatment for the patient awaiting transfer; and
               (2)  does not constitute authorization to retain the
  client in a correctional facility for competency restoration
  treatment.
         Sec. 592.087.  FINDING THAT CLIENT PRESENTS A DANGER. In
  making a finding under Section 592.086(b)(2) that, as a result of a
  mental disorder or mental defect, the client presents a danger to
  the client or others in the residential care facility in which the
  client is being treated or in the correctional facility, as
  applicable, the court shall consider:
               (1)  an assessment of the client's present mental
  condition; and
               (2)  whether the client has inflicted, attempted to
  inflict, or made a serious threat of inflicting substantial
  physical harm to the client's self or to another while in the
  facility.
         Sec. 592.088.  APPEAL. (a) A client may appeal an order
  under this subchapter in the manner provided by Section 593.056 for
  an appeal of an order committing the client to a residential care
  facility.
         (b)  An order authorizing the administration of medication
  regardless of the refusal of the client is effective pending an
  appeal of the order.
         Sec. 592.089.  EFFECT OF ORDER. (a) A person's consent to
  take a psychoactive medication is not valid and may not be relied on
  if the person is subject to an order issued under Section 592.086.
         (b)  The issuance of an order under Section 592.086 is not a
  determination or adjudication of mental incompetency and does not
  limit in any other respect that person's rights as a citizen or the
  person's property rights or legal capacity.
         Sec. 592.090.  EXPIRATION OF ORDER. (a) Except as provided
  by Subsection (b), an order issued under Section 592.086 expires on
  the anniversary of the date the order was issued.
         (b)  An order issued under Section 592.086 for a client
  awaiting trial in a criminal proceeding expires on the date the
  defendant is acquitted, is convicted, or enters a plea of guilty or
  the date on which charges in the case are dismissed. An order
  continued under this subsection shall be reviewed by the issuing
  court every six months.
         SECTION 4.  Articles 46B.086(a) and (b), Code of Criminal
  Procedure, are amended to read as follows:
         (a)  This article applies only to a defendant:
               (1)  who is determined under this chapter to be
  incompetent to stand trial;
               (2)  who either:
                     (A)  remains confined in a correctional facility,
  as defined by Section 1.07, Penal Code, for a period exceeding 72
  hours while awaiting transfer to an inpatient mental health
  facility, a residential care facility, or an outpatient treatment
  program;
                     (B)  is committed to an inpatient mental health
  facility or a residential care facility for the purpose of
  competency restoration;
                     (C)  is confined in a correctional facility while
  awaiting further criminal proceedings following competency
  restoration treatment; or
                     (D)  is subject to Article 46B.072, if the court
  has made the determinations required by Subsection (a) of that
  article;
               (3)  for whom a correctional facility that employs or
  contracts with a licensed psychiatrist, an inpatient mental health
  facility, a residential care facility, or an outpatient treatment
  program provider has prepared a continuity of care plan that
  requires the defendant to take psychoactive medications; and
               (4)  who, after a hearing held under Section 574.106 or
  592.086, Health and Safety Code, if applicable, has been found to
  not meet the criteria prescribed by Sections 574.106(a) and (a-1)
  or 592.086(a) and (b), Health and Safety Code, for court-ordered
  administration of psychoactive medications.
         (b)  If a defendant described by Subsection (a) refuses to
  take psychoactive medications as required by the defendant's
  continuity of care plan, the director of the correctional facility
  or outpatient treatment program provider, as applicable, shall
  notify the court in which the criminal proceedings are pending of
  that fact not later than the end of the next business day following
  the refusal.  The court shall promptly notify the attorney
  representing the state and the attorney representing the defendant
  of the defendant's refusal.  The attorney representing the state
  may file a written motion to compel medication.  The motion to
  compel medication must be filed not later than the 15th day after
  the date a judge issues an order stating that the defendant does not
  meet the criteria for court-ordered administration of psychoactive
  medications under Section 574.106 or 592.086, Health and Safety
  Code, except that, for a defendant in an outpatient treatment
  program, the motion may be filed at any time.
         SECTION 5.  This Act takes effect September 1, 2011.